Scholarlink

<p>Extracorporeal membrane oxygenation (ECMO) is a technique increasingly used in the practice of intensive therapy for extracorporeal gas exchange and/or circulatory support in patients with acute respiratory and/or cardiac failure, when conventional treatment modalities are ineffective. We aimed to investigate the association of antithrombin III with clinical outcomes in patients with cardiogenic shock caused by acute myocardial infarction undergoing ECMO. We retrospectively studied patients with acute myocardial infarction complicated by cardiogenic shock undergoing ECMO in four hospitals in China. The in-hospital mortality rate was 47.8% (194/406). The antithrombin III at admission of the in-hospital death group (n = 194) and the survival group (n = 212) were 45.70 ± 21.57 and 50.97 ± 25.37%, respectively. In-hospital mortality and acute kidney injury, and serum creatinine in the antithrombin III at admission &lt; 46% group were significantly higher than that in the antithrombin III at admission ≥ 46% group. By univariate and multivariate analysis, serum albumin &lt; 30&#xa0;g/L, low AT III at admission, and serum lactate were found to be related to in-hospital mortality. Our investigation demonstrated that low antithrombin III at admission was associated with in-hospital in cardiogenic shock secondary to acute myocardial infarction on ECMO, suggesting that antithrombin III may be an indicator of shock severity.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Antithrombin III at admission as a new predictive factors for mortality in ECMO for cardiogenic shock caused by acute myocardial infarction

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年5月19日

查看全文
  • Jing-bin Huang,
  • Zhuo Wei,
  • Zhai Huang,
  • Xiao-gang Tang,
  • De-fu Zeng,
  • Ke-qiang Huang,
  • Jian Li

摘要

Extracorporeal membrane oxygenation (ECMO) is a technique increasingly used in the practice of intensive therapy for extracorporeal gas exchange and/or circulatory support in patients with acute respiratory and/or cardiac failure, when conventional treatment modalities are ineffective. We aimed to investigate the association of antithrombin III with clinical outcomes in patients with cardiogenic shock caused by acute myocardial infarction undergoing ECMO. We retrospectively studied patients with acute myocardial infarction complicated by cardiogenic shock undergoing ECMO in four hospitals in China. The in-hospital mortality rate was 47.8% (194/406). The antithrombin III at admission of the in-hospital death group (n = 194) and the survival group (n = 212) were 45.70 ± 21.57 and 50.97 ± 25.37%, respectively. In-hospital mortality and acute kidney injury, and serum creatinine in the antithrombin III at admission < 46% group were significantly higher than that in the antithrombin III at admission ≥ 46% group. By univariate and multivariate analysis, serum albumin < 30 g/L, low AT III at admission, and serum lactate were found to be related to in-hospital mortality. Our investigation demonstrated that low antithrombin III at admission was associated with in-hospital in cardiogenic shock secondary to acute myocardial infarction on ECMO, suggesting that antithrombin III may be an indicator of shock severity.